• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有白细胞膜伪装的核壳纳米治疗剂用于生物医学应用。

Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications.

机构信息

School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai, China.

Department of Pediatrics, Maternity and Child Health Care of Zaozhuang, Zaozhuang, China.

出版信息

J Drug Target. 2020 Nov;28(9):873-881. doi: 10.1080/1061186X.2020.1757102. Epub 2020 Apr 24.

DOI:10.1080/1061186X.2020.1757102
PMID:32298153
Abstract

Core-shell nanoparticles have grown in popularity in the past few years due to their versatile features and multiple biomedical applications as drug delivery systems. In order to improve bioavailability and reduce adverse effects, the biomimetic concept has been integrated into core-shell architectural designs. In this regard, the 'camouflage' shell comprised of various cellular membranes renders these nanoparticles a multifunctional platform that combines the merits of native cellular membranes with the advantages of biomaterials. Since leukocytes have a specific tropism for inflammatory or tumour sites and can infiltrate into these lesions, the marriage of leukocyte cell membrane shell with functional nanoparticle core is expected to achieve long time circulation, targeted delivery and improved ability of overcoming certain physiological barriers. In this review, we focus mainly on the recent development of nanoparticles cloaked with the leukocyte membrane and their applications in different biomedical fields of interest, including cancer therapy, inflammatory regulation and immune modulation. Additionally, current challenges and future prospects of leukocyte membrane coated core-shell nanoparticles are also briefly discussed.

摘要

近年来,核壳纳米粒子因其多功能特性和作为药物传递系统的多种生物医学应用而受到广泛关注。为了提高生物利用度和降低不良反应,仿生学的概念已经被整合到核壳结构设计中。在这方面,由各种细胞膜组成的“伪装”壳使这些纳米粒子成为一种多功能平台,将天然细胞膜的优点与生物材料的优点结合在一起。由于白细胞对炎症或肿瘤部位具有特定的趋向性,并能浸润到这些病变部位,因此白细胞细胞膜与功能性纳米粒子核的结合有望实现长时间循环、靶向递送和提高克服某些生理屏障的能力。在这篇综述中,我们主要关注被白细胞膜包裹的纳米粒子的最新进展及其在癌症治疗、炎症调节和免疫调节等不同生物医学领域的应用。此外,还简要讨论了白细胞膜包覆的核壳纳米粒子目前面临的挑战和未来前景。

相似文献

1
Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications.具有白细胞膜伪装的核壳纳米治疗剂用于生物医学应用。
J Drug Target. 2020 Nov;28(9):873-881. doi: 10.1080/1061186X.2020.1757102. Epub 2020 Apr 24.
2
Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy.通过白细胞膜包覆仿生制备纳米治疗剂用于靶向治疗。
Colloids Surf B Biointerfaces. 2022 Nov;219:112803. doi: 10.1016/j.colsurfb.2022.112803. Epub 2022 Aug 24.
3
Macrophage Cell Membrane-Cloaked Nanoplatforms for Biomedical Applications.用于生物医学应用的巨噬细胞膜伪装纳米平台。
Small Methods. 2022 Aug;6(8):e2200289. doi: 10.1002/smtd.202200289. Epub 2022 Jun 29.
4
Development of Core-Shell Nanoparticle Drug Delivery Systems Based on Biomimetic Mineralization.基于仿生矿化的核壳型纳米粒子药物传递系统的研制。
Chembiochem. 2020 Oct 15;21(20):2871-2879. doi: 10.1002/cbic.202000105. Epub 2020 Jun 8.
5
Coating nanoparticles with cell membranes for targeted drug delivery.用细胞膜包覆纳米颗粒用于靶向给药。
J Drug Target. 2015;23(7-8):619-26. doi: 10.3109/1061186X.2015.1052074.
6
Stem cell membrane-coated abiotic nanomaterials for biomedical applications.用于生物医学应用的干细胞膜包覆的非生物纳米材料。
J Control Release. 2022 Nov;351:174-197. doi: 10.1016/j.jconrel.2022.09.012. Epub 2022 Sep 22.
7
Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.细胞膜仿生纳米粒子用于药物递送中的炎症和癌症靶向。
Biomater Sci. 2020 Jan 21;8(2):552-568. doi: 10.1039/c9bm01392j.
8
Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.白细胞介导的纳米治疗药物在炎症和肿瘤部位的递送
Theranostics. 2017 Jan 25;7(3):751-763. doi: 10.7150/thno.18069. eCollection 2017.
9
Cell Membrane Coated Nanoparticles: An Emerging Biomimetic Nanoplatform for Targeted Bioimaging and Therapy.细胞膜包覆纳米颗粒:一种新兴的仿生纳米平台,用于靶向生物成像和治疗。
Adv Exp Med Biol. 2018;1064:45-59. doi: 10.1007/978-981-13-0445-3_3.
10
Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system.细胞膜包覆的纳米颗粒:一种新型多功能仿生药物传递系统。
Drug Deliv Transl Res. 2023 Mar;13(3):716-737. doi: 10.1007/s13346-022-01252-0. Epub 2022 Nov 22.

引用本文的文献

1
Blood Cell Membrane-Coated Nanomaterials as a Versatile Biomimetic Nanoplatform for Antitumor Applications.血细胞膜包被的纳米材料作为一种用于抗肿瘤应用的多功能仿生纳米平台
Nanomaterials (Basel). 2024 Oct 31;14(21):1757. doi: 10.3390/nano14211757.
2
T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies.T 细胞和自然杀伤细胞膜伪装纳米粒子用于癌症和病毒治疗。
ACS Appl Bio Mater. 2024 May 20;7(5):2637-2659. doi: 10.1021/acsabm.4c00074. Epub 2024 Apr 30.
3
Biomimetic cell membrane-coated poly(lactic--glycolic acid) nanoparticles for biomedical applications.
用于生物医学应用的仿生细胞膜包覆聚乳酸-乙醇酸纳米粒
Bioeng Transl Med. 2022 Nov 2;8(2):e10441. doi: 10.1002/btm2.10441. eCollection 2023 Mar.
4
The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma.细胞膜包被纳米颗粒在胶质母细胞瘤中作为一种新型治疗方法的作用。
Front Mol Biosci. 2023 Jan 4;9:1083645. doi: 10.3389/fmolb.2022.1083645. eCollection 2022.
5
Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer.基于天然细胞的仿生细胞转化器用于消化系统癌症的靶向治疗。
Theranostics. 2022 Oct 9;12(16):7080-7107. doi: 10.7150/thno.75937. eCollection 2022.
6
COVID-19 inflammation and implications in drug delivery.COVID-19 炎症及其在药物输送中的意义。
J Control Release. 2022 Jun;346:260-274. doi: 10.1016/j.jconrel.2022.04.027. Epub 2022 Apr 27.
7
Engineering Macrophages Nanotechnology and Genetic Manipulation for Cancer Therapy.工程化巨噬细胞:用于癌症治疗的纳米技术与基因操纵
Front Oncol. 2022 Jan 6;11:786913. doi: 10.3389/fonc.2021.786913. eCollection 2021.
8
An Up-to-Date Review of Natural Nanoparticles for Cancer Management.用于癌症治疗的天然纳米颗粒最新综述
Pharmaceutics. 2021 Dec 22;14(1):18. doi: 10.3390/pharmaceutics14010018.